These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 832080)

  • 1. Effect of 1-alpha-hydroxycholecalciferol on magnesium metabolism in chronic renal failure.
    Kanis JA; Smith R; Walton RJ; Bartlett M
    Br Med J; 1977 Jan; 1(6055):211. PubMed ID: 832080
    [No Abstract]   [Full Text] [Related]  

  • 2. I alpha-hydroxycholecalciferol: a treatment of renal bone disease.
    Catto GR; MacLeod M; Pelc B; Kodicek E
    Br Med J; 1975 Jan; 1(5948):12-4. PubMed ID: 1120218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.
    von Herrath D; Schaefer K; Kraft D; Grigoleit HG; Koeppe P
    Klin Wochenschr; 1973 Oct; 51(19):979-81. PubMed ID: 4762587
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic effects of 1alpha-hydroxycholecalciferol on renal osteodystrophy.
    Castells S; Shai F; Gauthier B; Hashemi SE; Reddy CM; De Luca HF
    Curr Ther Res Clin Exp; 1976 Mar; 19(3):410-9. PubMed ID: 817872
    [No Abstract]   [Full Text] [Related]  

  • 5. Curative effects of 1alpha-hydroxycholecalciferol on calcium metabolism and bone disease in patients with chronic renal failure.
    Hirooka M; Wako H; Kaneko C; Ishikawa M; Sasaki S
    J Nutr Sci Vitaminol (Tokyo); 1975; 21(4):277-85. PubMed ID: 1214180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and phosphate metabolism in chronic renal failure, with particular reference to the effect of 1 alpha-hydroxyvitamin D3.
    Madsen S
    Acta Med Scand Suppl; 1980; 638():3-120. PubMed ID: 6929650
    [No Abstract]   [Full Text] [Related]  

  • 7. Absorption of calcium, magnesium and phosphate during chronic renal failure and the effect of vitamin D in rabbits.
    Tvedegaard E
    Z Versuchstierkd; 1985; 27(3-4):163-8. PubMed ID: 4050164
    [No Abstract]   [Full Text] [Related]  

  • 8. Zinc metabolism in patients with chronic renal failure during treatment with 1.25-dihydroxycholecalciferol: a controlled therapeutic trial.
    Kiilerich S; Christiansen C; Christensen MS; Naestoft J
    Clin Nephrol; 1981 Jan; 15(1):23-7. PubMed ID: 7214749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vitamine D3 and 25-hydroxycholecalciferol therapy in renal osteopathy: influence on serum calcium, phosphate, calcium phosphate products and on intestinal calcium absorption].
    Henning HV; Hesch RD; Hüsken WS; Quellhorst E; Scheler F
    Verh Dtsch Ges Inn Med; 1972; 78():1446-8. PubMed ID: 4665578
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].
    Hesch RD; Gerlach W; Henning HV; Emrich D; Scheler F; Kattermann R
    Dtsch Med Wochenschr; 1972 Nov; 97(45):1735-8 passim. PubMed ID: 4343379
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of 5,6-trans-25-hydroxycholecalciferol in relative vitamin D resistancy.
    Kraft D; Offermann G
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):75-80. PubMed ID: 859645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnesium intoxication during 1-alpha-hydroxycholecalciferol treatment.
    Kanis JA; Smith R; Walton RJ; Bartlett M
    Br Med J; 1976 Oct; 2(6040):878. PubMed ID: 990732
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnesium absorption and metabolism in patients with chronic renal failure and in patients with normal renal function.
    Spencer H; Lesniak M; Gatza CA; Osis D; Lender M
    Gastroenterology; 1980 Jul; 79(1):26-34. PubMed ID: 7380219
    [No Abstract]   [Full Text] [Related]  

  • 14. Recent clinical correlates of vitamin D metabolites and calcium metabolism.
    Nutr Rev; 1975 Jul; 33(7):209-10. PubMed ID: 1097964
    [No Abstract]   [Full Text] [Related]  

  • 15. The investigation and treatment of renal osteodystrophy.
    Catto GR; MacLeod M; Pelc B; Kodicek E
    Proc Eur Dial Transplant Assoc; 1975; 11():473-80. PubMed ID: 1197272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ionized calcium in renal failure --- a guideline for 1alpha-hydroxycholecalciferol treatment.
    Nielsen SP; Christiansen TF; Christensen MS; Clausen E; Krolner B; Lund B; Melsen F; Schaadt O; Sorensen OH
    Calcif Tissue Res; 1977 May; 22 Suppl():85-93. PubMed ID: 21026
    [No Abstract]   [Full Text] [Related]  

  • 17. Controlled therapeutic trial of 1alpha-hydroxycholecalciferol in chronic renal failure.
    Tougaard L; Sörensen E; Bröchner-Mortensen J; Christensen MS; Rödbro P; Sörensen AW
    Calcif Tissue Res; 1977 May; 22 Suppl():101-4. PubMed ID: 334342
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of uremic osteopathy. II. Effect of 5,6-trans-25-hydroxycholecalciferol in terminal kidney insufficiency].
    von Herrath D; Kraft D; Grigoleit HG; Schaefer K
    Dtsch Med Wochenschr; 1973 Jul; 98(28):1379-81. PubMed ID: 4197778
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intestinal absorption of Ca47 in chronic renal insufficiency before and after treatment with 1,25 dihydroxycholecalciferol].
    Vattimo A
    Minerva Med; 1979 Dec; 70(54):3705-7. PubMed ID: 523001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.